Learn when FILTER beats XLOOKUP, when it does not, and how to handle multiple matches, nth items, and multi-condition lookups with clear steps.

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.